Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons

Wolf Douglas; Skup Martha; Yang Hongbo; Fang Anna P.; Kageleiry Andrew; Chao Jingdong; Mittal Manish; Lebwohl Mark

首页> 外文期刊>Clinical therapeutics >Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons

【24h】

Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons

机译：与抗TNF抑制剂的切换或停止相关的临床结果以非医疗原因

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: This study evaluated clinical outcomes and health care resource utilization associated with nonmedical switching from or discontinuation of anti-tumor necrosis factor (TNF) therapies in US clinical practice.

机译：目的：本研究评估了与美国临床实践中的抗肿瘤坏死因子（TNF）疗法的非医疗切换相关的临床结果和医疗资源利用。

著录项

来源
《Clinical therapeutics》 |2017年第4期|共14页
作者
Wolf Douglas; Skup Martha; Yang Hongbo; Fang Anna P.; Kageleiry Andrew; Chao Jingdong; Mittal Manish; Lebwohl Mark;
展开▼
作者单位

Atlanta Gastroenterol Associates Atlanta GA USA;

AbbVie Inc N Chicago IL USA;

Anal Grp Inc Boston MA USA;

Anal Grp Inc Boston MA USA;

Anal Grp Inc Boston MA USA;

AbbVie Inc N Chicago IL USA;

AbbVie Inc N Chicago IL USA;

Icahn Sch Med Mt Sinai New York NY 10029 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
anti-TNF; autoimmune; biologic; non-medical switching; tumor necrosis factor;

机译：抗TNF;自身免疫;生物学;非医用切换;肿瘤坏死因子;

相似文献

外文文献
中文文献
专利

1. Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons [J] . Wolf Douglas, Skup Martha, Yang Hongbo, Clinical therapeutics . 2017,第4期

机译：与抗TNF抑制剂的切换或停止相关的临床结果以非医疗原因
2. Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis. [J] . Remy A, Avouac J, Gossec L, Clinical and experimental rheumatology . 2011,第1期

机译：类风湿关节炎中止第一种肿瘤坏死因子-α抑制剂后转用第二种肿瘤坏死因子-α抑制剂的临床意义：系统的文献综述和荟萃分析。
3. Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis [J] . Anouck R#233, my, Bernard Combe, Clinical and experimental rheumatology . 2011,第1期

机译：类风湿关节炎中止第一种肿瘤坏死因子-α抑制剂后转用第二种肿瘤坏死因子-α抑制剂的临床意义：系统的文献综述和荟萃分析
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. The application development outsourcing contract decision: The effect of service quality, relationship quality, satisfaction, and switching costs on continuation and discontinuation decisions. [D] . Whitten, G. Dwayne. 2004

机译：应用程序开发外包合同决策：服务质量，关系质量，满意度和转换成本对继续和终止决策的影响。
6. Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort [O] . Adrian Ciurea, Pascale Exer, Ulrich Weber, 2016

机译：停用第一种TNF抑制剂的原因是否会影响第二种TNF抑制剂在轴向性脊柱关节炎中的有效性？瑞士临床质量管理团队的结果
7. Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons [O] . Douglas Wolf, Martha Skup, Hongbo Yang, 2017

机译：与抗TNF抑制剂的切换或停止相关的临床结果以非医疗原因

Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons

摘要

著录项

相似文献

相关主题

期刊订阅